ISLAMABAD -- The Pakistan Pharmaceutical Manufacturers Association (PPMA) on Saturday urged Prime Minister Imran Khan for fast track approval of drugs needed in the current novel coronavirus (COVID-19) pandemic situation.
The pharmaceutical association in a letter written to the PM has asked for the fast registration of drugs Remdesivir and Faviipiravir. The letter written said that PPMA would like to acknowledge the efforts of DRAP in expediting the process for approval of drugs that are required immediately to cope-up with the situation of COVID-19 in our country.
It further said that currently, Pakistan in particular and South-East Asia in general are facing the most critical time of this pandemic as the number of cases and mortality is rising on a daily basis with alarming trends.
The letter said 'moreover, the most disturbing and concerning matter is that according to WHO and international health bodies, we have not yet reached our peak.'
'In this situation, the approach of DRAP for taking-up and approving applications for registration of relevant products on a fast track basis goes well with your valuable vision to...